US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inspira Technologies Oxy BHN Ltd Warrant

0.2000

+0.0000

Volume:- -

Turnover:- -

Market Cap:- -

PE:- -

High:0.2000

Open:0.2000

Low:0.2000

Close:0.2000

Loading ...

Overview Company News Filings

Market Alert: Inspira Technologies' Respiratory Tech Could Transform $19B Ventilator Market Amid Major Wave of Multi Billion Dollar Medtech Acquisitions

PESG Report: Inspira Technologies' AI-Powered Respiratory System Could Revolutionize Care for 20 Million Annual ICU Patients in Combined $25+ Billion Market

Inspira Technologies Releases CEO Update: Major Milestones Signal Next-Level Respiratory Care

Inspira Technologies Receives Nasdaq Notification Regarding Minimum Bid Requirement

PESG Report: Inspira Technologies Breaks new Ground with Positive Clinical Data for AI-Powered Blood Sensor Exceeding Expectations

Inspira Technologies Announces Positive Results from Clinical Study of HYLA Blood Sensor, Achieving 96% Accuracy

Inspira Achieves Positive Results of Above 95% For Preventing Bloodstream Infections

EXCLUSIVE: Inspira and Ennocure's Bio-Electronic Tech Uses Electric Stimulation to Help Prevent IV-Related Infections

Inspira Technologies Oxy B.H.N. Ltd. (IINN) Enhances HYLA™ Sensor with AI Oxygenation Indicator

PESG Report: Inspira Technologies Strengthens its AI-Powered Blood Sensor with new Capabilities, Intends to Share Clinical Findings Soon

Inspira Technologies Integrates New Oxygenation Indicator into AI-Powered HYLA Blood Sensor

EXCLUSIVE: Isreal-Based Inspira Technologies Integrates New Oxygenation Indicator Into HYLA Blood Sensor To Enhance Critical Care Monitoring

Inspira™ Introduces Advanced Features for INSPIRA™ ART100, Further Amplifying User and System Support

Inspira™ Technologies Prepares its First Life-Support Systems for Deployment at a Leading U.S. Hospital

Inspira™ Announces the Appointment of Tal Parnes as the New Chairman of the Board, Bringing Vast Experience in the Medical Technology and Pharmaceutical Sectors

Inspira™ Technologies Unveils Modular Configuration for Revolutionary VORTX™ Blood Oxygenation Delivery Technology

EXCLUSIVE: Inspira Technologies Unveils Modular Configuration For VORTX Blood Oxygenation Delivery Technology

Inspira™ Preparing Production in Response to Spread of Respiratory Virus in China

Inspira™ Technologies Flagship Technology to be Showcased at Arab Health Expo 2025 in Dubai

Inspira™ Announces Pricing of $3.2M Private Placement by New and Existing Investors of the Company

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IINNW/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IINNW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IINNW\",,,,,undefined,":{"symbol":"IINNW","market":"US","secType":"STK","nameCN":"Inspira Technologies Oxy BHN Ltd Warrant","latestPrice":0.2,"timestamp":1743624000000,"preClose":0.2,"halted":0,"volume":0,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":0,"latestTime":"04-02 16:00:00 EDT","open":0.2,"high":0.2,"low":0.2,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1743667200000},"marketStatusCode":5,"adr":0,"listingDate":1626235200000,"exchange":"NASDAQ","adjPreClose":0.2,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IINNW\",,,,,undefined,":{"symbol":"IINNW","floatShares":0,"roa":"-62.52%","roe":"-122.04%","lyrEps":0,"shares":0,"dividePrice":0,"high":0.2,"amplitude":0,"preClose":0.2,"low":0.2,"week52Low":0.1701,"pbRate":"0.00","week52High":0.99,"institutionHeld":0,"latestPrice":0.2,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0.2,"prevYearClose":0.19,"prevWeekClose":0.2123,"prevMonthClose":0.2341,"prevQuarterClose":0.2341,"fiveDayClose":0.2123,"twentyDayClose":0.23,"sixtyDayClose":0.19},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IINNW\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2522705465","title":"Market Alert: Inspira Technologies' Respiratory Tech Could Transform $19B Ventilator Market Amid Major Wave of Multi Billion Dollar Medtech Acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2522705465","media":"Business Wire","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522705465?lang=en_us&edition=fundamental","pubTime":"2025-03-25 01:59","pubTimestamp":1742839140,"startTime":"0","endTime":"0","summary":"As FDA-cleared INSPIRA ART100 system begins deployment at top New York hospital amid $21B+ in recent medtech acquisitions including J&J's $13.1B Shockwave deal and Boston Scientific's $3.7B Axonics purchase, Company's innovative HYLA blood sensor achieves 96% accuracy in clinical trials as Inspira advances its flagship INSPIRA ART500 system targeting 20 million annual respiratory patients with AI technology. NEW YORK, March 24, 2025----Market News Alerts Reports: Inspira Technologies * is reported beginning deployment of its FDA-cleared INSPIRA ART100 system at a leading New York cardiothoracic program ranked among the top 15% nationally, marking a significant commercialization milestone in a sector experiencing unprecedented M&A activity. The medtech industry saw multiple billion-dollar acquisitions in 2024, including Johnson & Johnson's $13.1 billion acquisition of Shockwave Medical, Edwards' $4.2 billion sale of its Critical Care business to BD, and Boston Scientific's $3.7 billion ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/market-alert-inspira-technologies-respiratory-175900693.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","BK4539","IINN","IINNW"],"gpt_icon":0},{"id":"2520989778","title":"PESG Report: Inspira Technologies' AI-Powered Respiratory System Could Revolutionize Care for 20 Million Annual ICU Patients in Combined $25+ Billion Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2520989778","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520989778?lang=en_us&edition=fundamental","pubTime":"2025-03-19 01:17","pubTimestamp":1742318220,"startTime":"0","endTime":"0","summary":"Inspira Technologies' remarkable 96% accuracy in HYLA blood sensor clinical trials positions the company to target both the $5.7 billion blood gas analyzer market and the $19 billion mechanical ventilation market; Strengthened by FDA-cleared ART100 already being deployed in U.S. hospitals and HYLA FDA submission on track for H2 2025; Company shifts focus to now accelerate development of flagship INSPIRA ART500 system, potentially transforming respiratory care for millions of ICU patients worldwide. NEW YORK, March 18, 2025----PESG Research releases an update following Inspira Technologies' * recent strategic developments and clinical achievements: Inspira has emerged as a potential disruptive force in respiratory care with its integrated technology approach. The company's recent clinical studies demonstrating 96% accuracy for its AI-powered HYLA blood sensor represent a significant technological validation as it targets multiple high-value healthcare segments.Looking ahead, the company","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pesg-report-inspira-technologies-ai-171700072.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","IINNW","BK4539","IINN","ICU"],"gpt_icon":0},{"id":"2519404877","title":"Inspira Technologies Releases CEO Update: Major Milestones Signal Next-Level Respiratory Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2519404877","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519404877?lang=en_us&edition=fundamental","pubTime":"2025-03-14 19:00","pubTimestamp":1741950000,"startTime":"0","endTime":"0","summary":"RA'ANANA, Israel, March 14, 2025 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd.  , a pioneering force in the evolution of respiratory support and real-time blood-monitoring technologies, is pleased to share this update to shareholders from its Chief Executive Officer, Director, and Co-founder, Mr. Dagi Ben Noon.We founded Inspira Technologies with a bold vision: to radically transform life-support for the millions of patients who each year face the harsh realities of mechanical ventilation. Today, I believe that the INSPIRA ART500 system we are developing stands poised to become the breakthrough solution that could profoundly reshape respiratory care.In this letter, I want to provide my perspective on some of our recent achievements, how they connect to our strategic direction and long term vision, and some details on our upcoming roadmap.HYLA Blood Sensor A unique, continuous, real-time blood-monitoring solution with the power to replace routine blood draws. Early clinical studi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/inspira-technologies-releases-ceo-major-110000511.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inspira-technologies-releases-ceo-major-110000511.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IINN","IINNW"],"gpt_icon":0},{"id":"2519864883","title":"Inspira Technologies Receives Nasdaq Notification Regarding Minimum Bid Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2519864883","media":"PR Newswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519864883?lang=en_us&edition=fundamental","pubTime":"2025-03-14 04:30","pubTimestamp":1741897800,"startTime":"0","endTime":"0","summary":"RA'ANANA, Israel, March 13, 2025 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd.  , a pioneer in innovative life-support and diagnostic technologies, today announced that on March 10, 2025, the Company received a written notice  from the Nasdaq Stock Market LLC indicating that the Company was not in compliance with Nasdaq Listing Rule 5550, as the Company's closing bid price for its ordinary shares, or Ordinary Shares, was below $1.00 per share for the last 30 consecutive business days.Inspira Technologies is developing innovative respiratory support and diagnostics technologies. The Company's flagship INSPIRA ART system aims to revolutionize critical care by enabling patients to remain awake during treatment while stabilizing oxygen levels without mechanical ventilation. The FDA-cleared INSPIRA ART100 system has received regulatory approvals for Cardiopulmonary Bypass procedures in both the U.S. and for Cardiopulmonary Bypass procedures and Extra Corporeal Membrane Oxygenation in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/inspira-technologies-receives-nasdaq-notification-203000449.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inspira-technologies-receives-nasdaq-notification-203000449.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2092937221.SGD","PSQ","TQQQ","LU2413666699.HKD","LU2041044095.USD","IE00BN0W2T93.GBP","NQmain","BK4567","LU2210149790.SGD","IE00B3QW5Z07.USD","A","IE00BN0W2W23.USD","NVIW.SI","LU1165135440.EUR","LU2210150020.SGD","LU2413666426.HKD","IINN","BK4121","BK4588","SQQQ","LU1543694498.USD","LU2095319765.USD",".IXIC","USAW.SI","QLD","BK4585","LU0347712357.USD","BK4112","MNQmain","USJW.SI","LU1721428933.USD","TSYW.SI","IINNW","IE00BGHQF748.EUR","QID","IE00B64PRP62.GBP","IE00BKPKM429.USD","NDAQ","IE00BN0W2V16.EUR"],"gpt_icon":1},{"id":"2517801917","title":"PESG Report: Inspira Technologies Breaks new Ground with Positive Clinical Data for AI-Powered Blood Sensor Exceeding Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2517801917","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517801917?lang=en_us&edition=fundamental","pubTime":"2025-03-05 21:46","pubTimestamp":1741182360,"startTime":"0","endTime":"0","summary":"Inspira Technologies* reports groundbreaking clinical results for its AI-powered HYLA blood sensor, achieving 96% accuracy in a key parameter and 92.3% accuracy in detecting oxygen deficiencies. These impressive findings provide new validation the company's innovative non-invasive monitoring technology and strengthen its position in both the $5.7 billion blood gas analyzer market and the $19 billion mechanical ventilation market. With FDA submission on track for H2 2025 and the INSPIRA ART100 system already being deployed to U.S. hospitals, the company continues to build momentum in its multi-pronged strategy to revolutionize critical care.NEW YORK, March 05, 2025----PESG Research releases an update following groundbreaking clinical evaluation results: Inspira Technologies*  has reported exceptional clinical study outcomes for its HYLA blood sensor, with 96% accuracy achieved in a key parameter compared to traditional blood analyzers. This milestone achievement validates the company's ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pesg-report-inspira-technologies-breaks-134600830.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","IINN","BK4539","IINNW"],"gpt_icon":0},{"id":"2516679239","title":"Inspira Technologies Announces Positive Results from Clinical Study of HYLA Blood Sensor, Achieving 96% Accuracy","url":"https://stock-news.laohu8.com/highlight/detail?id=2516679239","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516679239?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:30","pubTimestamp":1741095000,"startTime":"0","endTime":"0","summary":"Inspira's AI-powered continuous blood monitoring technology demonstrated a high degree of accuracy in a key parameter, targeting multiple multi-billion-dollar market segments; Company plans to advance with ongoing clinical study following this success; FDA submission planned for H2 2025. RA'ANANA, Israel, March 4, 2025 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd.  , a pioneer in innovative life-support and diagnostic technologies, today announced positive results from the clinical study of its AI-powered HYLA blood sensor. Inspira believes that these breakthrough results strengthen the Company's progress in developing its innovative real-time blood monitoring capabilities, as a means of enabling early diagnosis and personalized care without the need for intermittent blood draws.\"We consider these exceptional results that mark a pivotal milestone in our mission to transform critical care monitoring,\" said Dagi Ben-Noon, CEO of Inspira Technologies. \"We believe that achieving 96%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/inspira-technologies-announces-positive-results-133000608.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inspira-technologies-announces-positive-results-133000608.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IINNW","BK4539","BK4082","IINN"],"gpt_icon":0},{"id":"2510800558","title":"Inspira Achieves Positive Results of Above 95% For Preventing Bloodstream Infections","url":"https://stock-news.laohu8.com/highlight/detail?id=2510800558","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510800558?lang=en_us&edition=fundamental","pubTime":"2025-02-11 20:00","pubTimestamp":1739275200,"startTime":"0","endTime":"0","summary":"The ex-vivo testing demonstrated significant bacterial reduction for the innovative IV dressing technology aimed at preventing bloodstream infections in critical patients. In ex-vivo porcine skin model testing, the bio-electronic patch demonstrated a 95% reduction in bacterial presence within 4 hours, with continued effectiveness observed over a 24-hour period. The technology, which uses physical electric stimulation rather than chemical agents, showed promising results in preventing pathogen growth on treated surfaces.\"We believe that these initial results represent an important milestone in our development of next-generation infection prevention technology,\" said Dagi Ben-Noon, CEO of Inspira. \"With an estimated 250,000 bloodstream infections related to intravenous lines occurring worldwide each year, we believe this novel approach could potentially offer significant advantages in critical care settings.\"","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/inspira-achieves-positive-results-above-120000683.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inspira-achieves-positive-results-above-120000683.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IINN","BK4539","BK4082","IINNW"],"gpt_icon":0},{"id":"2510800555","title":"EXCLUSIVE: Inspira and Ennocure's Bio-Electronic Tech Uses Electric Stimulation to Help Prevent IV-Related Infections","url":"https://stock-news.laohu8.com/highlight/detail?id=2510800555","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510800555?lang=en_us&edition=fundamental","pubTime":"2025-02-11 19:45","pubTimestamp":1739274342,"startTime":"0","endTime":"0","summary":"On Tuesday, Inspira Technologies OXY B.H.N.  announced positive initial results from its previously reported collaboration with Ennocure MedTech to develop a novel bio-electronic treatment for preventing bloodstream infections.In ex-vivo porcine skin model testing, the bio-electronic patch demonstrated a 95% reduction in bacterial presence within 4 hours, with continued effectiveness observed over 24 hours.The technology, which uses physical electric stimulation rather than chemical agents, showed promising results in preventing pathogen growth on treated surfaces.Also Read: Monday.com Beats Q4 Earnings Estimates, Boasts 32% Revenue Growth: CEO Calls AI A Game-Changer. Inspira Technologies chief Dagi Ben-Noon noted an estimated 250,000 bloodstream infections related to intravenous lines occurring worldwide yearly. The approach could offer significant advantages in critical care settings.Bio-electronic technology can address several key challenges associated with traditional IV dressing","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exclusive-inspira-ennocures-bio-electronic-114542662.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","BK4082","IINNW","IINN"],"gpt_icon":0},{"id":"2509209442","title":"Inspira Technologies Oxy B.H.N. Ltd. (IINN) Enhances HYLA™ Sensor with AI Oxygenation Indicator","url":"https://stock-news.laohu8.com/highlight/detail?id=2509209442","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509209442?lang=en_us&edition=fundamental","pubTime":"2025-02-07 00:36","pubTimestamp":1738859817,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 12 Trending AI Stocks on Latest News and Ratings.In this article, we are going to take a look at where Inspira Technologies Oxy B.H.N. Ltd.  stands against the other trending AI stocks.DeepSeek may have astounded the tech world following its emergence, but not everyone seems to be a fan. In the latest news report, Reuters reported that South Korea’s industry ministry temporarily blocked access to Chinese artificial intelligence startup DeepSeek due tosecurity concerns. The government urges caution on generative AI services, particularly calling out ministries and agencies about using AI services such as ChatGPT and DeepSeek at work.Why are we interested in the stocks that hedge funds pile into?The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inspira-technologies-oxy-b-h-163657696.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TQQQ","IINNW","QID",".IXIC","QLD","IINN","MNQmain","TSYW.SI","SQQQ","NVIW.SI","BK4539","PSQ","USAW.SI","NQmain","USJW.SI","BK4082"],"gpt_icon":1},{"id":"2509527644","title":"PESG Report: Inspira Technologies Strengthens its AI-Powered Blood Sensor with new Capabilities, Intends to Share Clinical Findings Soon","url":"https://stock-news.laohu8.com/highlight/detail?id=2509527644","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509527644?lang=en_us&edition=fundamental","pubTime":"2025-02-06 21:27","pubTimestamp":1738848420,"startTime":"0","endTime":"0","summary":"Inspira Technologies* advancement of its AI-powered blood monitoring technology comes amid robust growth in medical technology M&A, with Q3 2024 seeing 275 deals worth $34 billion - a 35% increase year-over-year. The integration of this new oxygenation indicator strengthens the Company's position in both the $2.5 billion blood gas analysis market and, through the FDA-cleared INSPIRA ART100 system, the $19 billion mechanical ventilation market. With clinical evaluations of the HYLA blood sensor underway at Sheba Medical Center and preliminary results reportedly expected in the near future, the Company continues to execute its strategy of combining AI-enhanced monitoring capabilities with innovative respiratory support solutions.While HYLA advances through clinical evaluation, Inspira has already achieved significant business milestones with its INSPIRA ART100 system. Following FDA 510 clearance in May 2024 for Cardiopulmonary Bypass procedures and subsequent Israeli AMAR certification, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pesg-report-inspira-technologies-strengthens-132700954.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IINN","BK4082","BK4539","IINNW"],"gpt_icon":0},{"id":"2509286215","title":"Inspira Technologies Integrates New Oxygenation Indicator into AI-Powered HYLA Blood Sensor","url":"https://stock-news.laohu8.com/highlight/detail?id=2509286215","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509286215?lang=en_us&edition=fundamental","pubTime":"2025-02-05 21:30","pubTimestamp":1738762200,"startTime":"0","endTime":"0","summary":"Inspira Technologies develops its innovative AI-powered HYLA technology with advanced blood testing capability, enabling continuous monitoring of tissue oxygenation and early hypoxia detection; Company expects to release preliminary clinical results for the sensor in the near future. RA'ANANA, Israel, Feb. 5, 2025 /PRNewswire/ --Inspira Technologies OXY B.H.N. Ltd.  , a pioneer in breakthrough life-support technology, today announced the integration of a next-generation oxygenation indicator into its AI-powered HYLA blood sensor technology, designed to enable the rapid detection of critical oxygen-related conditions without the need for intermittent blood draws.Clinical validation of the enhanced HYLA blood sensor, with its new oxygenation indicator, is currently underway at Sheba Medical Center, ranked among the world's top 10 smart hospitals by Newsweek. The Company is optimistic about the ongoing evaluations and expects to share preliminary clinical results in the near future. The n","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/inspira-technologies-integrates-oxygenation-indicator-133000713.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inspira-technologies-integrates-oxygenation-indicator-133000713.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","BK4082","IINNW","IINN"],"gpt_icon":0},{"id":"2509851372","title":"EXCLUSIVE: Isreal-Based Inspira Technologies Integrates New Oxygenation Indicator Into HYLA Blood Sensor To Enhance Critical Care Monitoring","url":"https://stock-news.laohu8.com/highlight/detail?id=2509851372","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509851372?lang=en_us&edition=fundamental","pubTime":"2025-02-05 21:15","pubTimestamp":1738761317,"startTime":"0","endTime":"0","summary":"On Wednesday, Inspira Technologies OXY B.H.N. Ltd.  announced the integration of a next-generation oxygenation indicator into its AI-powered HYLA blood sensor technology.This technology is designed to enable the rapid detection of critical oxygen-related conditions without the need for intermittent blood draws.The company says the integration represents a significant enhancement in critical care monitoring.The technology is designed to provide data through real-time and continuous monitoring of oxygenation therapy, enabling the rapid detection of tissue hypoxia and the early warning of respiratory complications.The advanced AI-powered system is designed to indicate lung function levels and monitor vital blood parameters, positioning HYLA as a potential game-changer in the $2.5 billion point-of-care testing and arterial blood gas analyzer market.Clinical validation of the enhanced HYLA blood sensor, with its new oxygenation indicator, is underway at Sheba Medical Center.This article EXC","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exclusive-isreal-based-inspira-technologies-131517784.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","IINNW","BK4082","IINN"],"gpt_icon":0},{"id":"2506720773","title":"Inspira™ Introduces Advanced Features for INSPIRA™ ART100, Further Amplifying User and System Support","url":"https://stock-news.laohu8.com/highlight/detail?id=2506720773","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506720773?lang=en_us&edition=fundamental","pubTime":"2025-01-27 21:30","pubTimestamp":1737984600,"startTime":"0","endTime":"0","summary":"RA'ANANA, Israel, Jan. 27, 2025 /PRNewswire/ --Inspira Technologies OXY B.H.N. Ltd. , a leader in innovative medical technology, has announced the addition of new support features to the INSPIRA ART100, a system cleared by the U.S. Food and Drug Administration. These enhancements are designed to assist medical team procedures to reduce staff overhead and improve efficiency, further solidifying Inspira's position at the forefront of extracorporeal life support technology.Inspira Technologies is an innovative medical technology company targeting to better the life support and respiratory treatment arena. The Company is developing a breakthrough Augmented Respiration Technology , a groundbreaking device poised to revolutionize and potentially replace the $19 billion mechanical ventilation market. With 20 million intensive care unit patients with acute respiratory failure each year, many of whom rely on mechanical ventilators, the INSPIRA ART offers a potential alternative by elevating and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/inspira-introduces-advanced-features-inspira-133000968.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inspira-introduces-advanced-features-inspira-133000968.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IINN","IE0031619046.USD","IE00B7SZL793.SGD","IE00B19Z4B17.USD","IE00B66KJ199.SGD","IINNW","AEIS","BK4157"],"gpt_icon":0},{"id":"2505406277","title":"Inspira™ Technologies Prepares its First Life-Support Systems for Deployment at a Leading U.S. Hospital","url":"https://stock-news.laohu8.com/highlight/detail?id=2505406277","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505406277?lang=en_us&edition=fundamental","pubTime":"2025-01-22 21:30","pubTimestamp":1737552600,"startTime":"0","endTime":"0","summary":"RA'ANANA, Israel, Jan. 22, 2025 /PRNewswire/ -- Inspira Technologies Oxy B.H.N. Ltd.  , , a groundbreaking respiratory support technology company, announced that its INSPIRA ART100 systems have been delivered to Glo-Med Networks Inc.  and are now being prepared for their first planned deployment at a leading U.S. hospital. The deployment will include direct support from Inspira's team alongside Glo-Med's experts, ensuring a seamless integration of the revolutionary life-support technology into clinical use.Designed in collaboration with leading U.S. clinicians, the INSPIRA ART100 cardiopulmonary bypass system revolutionizes extracorporeal blood circulation by combining cutting-edge technology with intuitive design to optimize patient care during crucial times. The INSPIRA ART100 is planned to be integrated with the HYLA, a continuous blood monitoring technology designed to potentially detect real-time changes in patient condition. The HYLA is undergoing clinical evaluations at Sheba Ho","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/inspira-technologies-prepares-first-life-133000282.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inspira-technologies-prepares-first-life-133000282.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IINN","BK4539","BK4082","IINNW"],"gpt_icon":0},{"id":"2505273801","title":"Inspira™ Announces the Appointment of Tal Parnes as the New Chairman of the Board, Bringing Vast Experience in the Medical Technology and Pharmaceutical Sectors","url":"https://stock-news.laohu8.com/highlight/detail?id=2505273801","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505273801?lang=en_us&edition=fundamental","pubTime":"2025-01-21 21:30","pubTimestamp":1737466200,"startTime":"0","endTime":"0","summary":"Mr. Parnes brings a wealth of experience and expertise to his new role at Inspira. With a distinguished career spanning over three decades in the technology sector, with a special focus in the medical technology and pharmaceutical industries, Mr. Parnes has consistently demonstrated exceptional leadership and strategic vision.As a serial entrepreneur, Parnes has demonstrated his ability to drive innovation and growth across various high-tech sectors, including medical technology, communications and defense. Mr. Parnes is familiar with the Company and its technology, having served as an independent director of the Company since July 2021.Inspira Technologies is an innovative medical technology company in the life support and respiratory treatment arena. The Company has developed a breakthrough Augmented Respiration Technology , a groundbreaking device poised to revolutionize the$19 billionmechanical ventilation market. With 20 million intensive care unit patients with acute respiratory ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/inspira-announces-appointment-tal-parnes-133000236.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inspira-announces-appointment-tal-parnes-133000236.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IINN","IINNW"],"gpt_icon":0},{"id":"2503573418","title":"Inspira™ Technologies Unveils Modular Configuration for Revolutionary VORTX™ Blood Oxygenation Delivery Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2503573418","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503573418?lang=en_us&edition=fundamental","pubTime":"2025-01-14 21:30","pubTimestamp":1736861400,"startTime":"0","endTime":"0","summary":"The technology has the potential to provide life-saving support for the approximately 20 million ICU patients with respiratory failure annually. RA'ANANA, Israel, Jan. 14, 2025 /PRNewswire/ --Inspira Technologies OXY B.H.N. Ltd.  , a leader in life-support technology innovation, is proud to announce the development of a modular configuration for its groundbreaking VORTX blood oxygenation delivery technology. We believe that this innovative approach represents a significant advancement in the field of extracorporeal oxygenation and has the potential to transform critical care practices worldwide.The unique modular configuration of the VORTX blood oxygenation delivery system is expected to extend the INSPIRA ART's range of blood oxygen enrichment and carbon dioxide removal, potentially expanding the versatility of the INSPIRA ART. The flagship INSPIRA ART system targets to revolutionize the $19 Billion Mechanical ventilation market, and is being designed to elevate and stabilize declinin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/inspira-technologies-unveils-modular-configuration-133000313.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inspira-technologies-unveils-modular-configuration-133000313.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IINN","IINNW","BK4539","BK4082"],"gpt_icon":0},{"id":"2503573490","title":"EXCLUSIVE: Inspira Technologies Unveils Modular Configuration For VORTX Blood Oxygenation Delivery Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2503573490","media":"Benzinga","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503573490?lang=en_us&edition=fundamental","pubTime":"2025-01-14 21:20","pubTimestamp":1736860841,"startTime":"0","endTime":"0","summary":"On Tuesday, Inspira Technologies OXY B.H.N. Ltd.  announced the development of a modular configuration for its VORTX blood oxygenation delivery technology.As per the company website, the VORTX technology is designed to enrich small volumes of blood with oxygen and simultaneously remove carbon dioxide to elevate saturation levels to 95% or higher.The VORTX aims to oxygenate blood without fiber membranes, which are known to cause harmful turbulence, friction, and shear forces, increasing damage to blood cells and clotting.The modular configuration of the VORTX blood oxygenation delivery system is expected to extend the INSPIRA Augmented Respiration Technology’s  range of blood oxygen enrichment and carbon dioxide removal.The flagship INSPIRA ART system aims to revolutionize the $19 Billion Mechanical ventilation market and is being designed to elevate and stabilize declining oxygen saturation levels in patients while they are awake and without a ventilator.In September, Inspira secured a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exclusive-inspira-technologies-unveils-modular-132041306.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"EXCLUSIVE: Inspira Technologies Unveils Modular Configuration For VORTX Blood Oxygenation Delivery Technology","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IINN","BK4539","BK4082","IINNW"],"gpt_icon":0},{"id":"2502851125","title":"Inspira™ Preparing Production in Response to Spread of Respiratory Virus in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2502851125","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502851125?lang=en_us&edition=fundamental","pubTime":"2025-01-10 19:15","pubTimestamp":1736507700,"startTime":"0","endTime":"0","summary":"Inspira is already in discussions with leading providers in affected regions to evaluate demand for advance respiratory solutions and deployment of the INSPIRA ART100 device, ensuring rapid response capabilities in case of increased demand.As global health authorities monitor the hMPV outbreak, Inspira believes that it is well-positioned to meet potential increased demand for advanced respiratory support systems. Inspira is working closely with suppliers to secure necessary raw materials and components to meet potential demand spikes. The Company is following the hMPV situation globally and working to adjust production plans as needed.\"While hMPV is not a new virus, and experts indicate the current outbreak is part of normal seasonal patterns, Inspira believes in being prepared,\" said Dagi Ben-Noon, CEO of Inspira. \"Our increased production capacity will help ensure healthcare providers have access to vital respiratory care equipment should the need arise.\". In June and July 2024, resp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/inspira-preparing-production-response-spread-111500775.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inspira-preparing-production-response-spread-111500775.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IINNW","IINN"],"gpt_icon":0},{"id":"2501121209","title":"Inspira™ Technologies Flagship Technology to be Showcased at Arab Health Expo 2025 in Dubai","url":"https://stock-news.laohu8.com/highlight/detail?id=2501121209","media":"PR Newswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501121209?lang=en_us&edition=fundamental","pubTime":"2025-01-07 21:15","pubTimestamp":1736255700,"startTime":"0","endTime":"0","summary":"Visitors at Glo-Med Network Inc's booth can explore Inspira's cutting-edge respiratory solutions, with the FDA-cleared INSPIRAART100, showcasing the future of respiratory care. RA'ANANA, Israel, Jan. 7, 2025 /PRNewswire/ -- Inspira Technologies Oxy B.H.N. Ltd. , , a groundbreaking respiratory support technology company,is pleased to announce that the INSPIRAART100, a cardiopulmonary bypass system will be showcased at Arab Health 2025, one of the largest healthcare exhibitions in the Middle East, expected to have over 3,800 exhibitors and over 180 visiting countries.The INSPIRA ART100 system has already attained U.S. Food and Drug Administration  clearance for Cardiopulmonary Bypass procedures. The INSPIRA ART100 system utilizes a technique that adds oxygen to the blood and removes carbon dioxide, with the enriched blood being circulated back to the patient, taking over the functionality of the heart and/or lungs in critical care patients.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/inspira-technologies-flagship-technology-showcased-131500557.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inspira-technologies-flagship-technology-showcased-131500557.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","BK4082","IINNW","IINN"],"gpt_icon":0},{"id":"2494381291","title":"Inspira™ Announces Pricing of $3.2M Private Placement by New and Existing Investors of the Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2494381291","media":"PR Newswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494381291?lang=en_us&edition=fundamental","pubTime":"2024-12-27 23:09","pubTimestamp":1735312140,"startTime":"0","endTime":"0","summary":"RA'ANANA, Israel, Dec. 27, 2024 /PRNewswire/ -- Inspira Technologies Oxy B.H.N. Ltd. , , ,a groundbreaking respiratory support technology company, a pioneer in life-support technology, today announced the pricing of a private placement offering consisting of the issuance and sale of 4,608,715 ordinary shares, no par value per share  and ordinary warrants to purchase up to 4,608,715 ordinary shares, at a combined purchase price of $0.70. The ordinary warrants have a term of eighteen months and have an exercise price of $1.10 per share.The Company intends to use the net proceeds from the offering for working capital and general corporate purposes. The closing of the private placement is expected to occur on or about December 30, 2024, subject to the satisfaction of certain customary closing conditions.Dawson James Securities is acting as the exclusive placement agent for the private placement.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/inspira-announces-pricing-3-2m-150900214.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inspira-announces-pricing-3-2m-150900214.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IINNW","ISBC","BK4211","BK4539","IINN","BK4082"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":25}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IINNW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IINNW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IINNW\",market:\"US\",delay:false,,,undefined,":{}}}